List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 2931 studies with search of:   United States, Wisconsin
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etexilate;   Drug: Warfarin
2 Recruiting Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Condition: Breast Cancer
Interventions: Drug: bevacizumab;   Drug: letrozole;   Drug: placebo;   Drug: tamoxifen citrate
3 Recruiting Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
Conditions: Metastatic Cancer;   Prostate Cancer
Interventions: Drug: placebo;   Drug: zoledronic acid
4 Completed Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: insulin detemir
5 Active, not recruiting Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
Condition: Melanoma (Skin)
Interventions: Drug: everolimus;   Drug: temozolomide;   Procedure: flow cytometry;   Procedure: immunohistochemistry staining method;   Procedure: immunologic technique;   Procedure: reverse transcriptase-polymerase chain reaction
6 Active, not recruiting Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
Condition: Prostate Cancer
Intervention: Procedure: radiation therapy
7 Completed Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Brain and Central Nervous System Tumors;   Lymphoma;   Neuroblastoma;   Retinoblastoma;   Sarcoma;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Drug: becatecarin
8 Completed Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: leucovorin calcium;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: nelarabine;   Drug: pegaspargase;   Drug: prednisone;   Drug: thioguanine;   Drug: vincristine sulfate;   Procedure: radiation therapy
9 Active, not recruiting Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
Condition: Breast Cancer
Interventions: Drug: CMF regimen;   Drug: capecitabine;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: fluorouracil;   Drug: methotrexate;   Procedure: adjuvant therapy
10 Active, not recruiting Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial CAN-NCIC-MA27
Conditions: Breast Cancer;   Cancer-Related Problem/Condition
Interventions: Drug: alendronate sodium;   Drug: calcium carbonate;   Drug: calcium citrate;   Drug: calcium gluconate;   Drug: cholecalciferol;   Drug: risedronate sodium;   Procedure: dual x-ray absorptometry;   Procedure: laboratory biomarker analysis
11 Recruiting Bevacizumab, Sorafenib, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Drug: bevacizumab;   Drug: sorafenib tosylate;   Drug: temsirolimus
12 Active, not recruiting Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium
Conditions: Bladder Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter;   Urethral Cancer
Intervention: Drug: sorafenib tosylate
13 Recruiting Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: clodronate disodium;   Drug: ibandronate sodium;   Drug: zoledronic acid
14 Recruiting Bevacizumab, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Stage II or Stage III Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: bevacizumab;   Drug: dexamethasone;   Drug: lenalidomide;   Procedure: fluorescence in situ hybridization;   Procedure: immunoenzyme technique;   Procedure: immunohistochemistry staining method;   Procedure: laboratory biomarker analysis;   Procedure: polymorphism analysis
15 Recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Condition: Lung Cancer
Interventions: Drug: bevacizumab;   Drug: carboplatin;   Drug: cisplatin;   Drug: docetaxel;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Drug: vinorelbine ditartrate
16 Recruiting Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery
Condition: Melanoma (Skin)
Interventions: Drug: bevacizumab;   Drug: carboplatin;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Drug: temozolomide
17 Active, not recruiting Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Condition: Breast Cancer
Interventions: Drug: raloxifene;   Drug: tamoxifen citrate
18 Recruiting Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Condition: Esophageal Cancer
Interventions: Drug: cetuximab;   Drug: cisplatin;   Drug: epirubicin hydrochloride;   Drug: fluorouracil;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium;   Drug: oxaliplatin
19 Active, not recruiting Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
Conditions: Brain and Central Nervous System Tumors;   Cancer-Related Problem/Condition
Interventions: Procedure: management of therapy complications;   Procedure: quality-of-life assessment
20 Active, not recruiting Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer
Condition: Lung Cancer
Intervention: Drug: cetuximab

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services